APO Research
Talk to an analyst

APO RESEARCH · REPORT

cfDNA Testing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global cfDNA Testing Market Outlook and Growth Opportunities 2026

8 January 2026193 pages

Choose your research edition.

Industry ResearchcfDNA Testing Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal cfDNA Testing Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal cfDNA Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal cfDNA Testing Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal cfDNA Testing Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global cfDNA Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for cfDNA Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for cfDNA Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for cfDNA Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the cfDNA Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the cfDNA Testing market include Illumina, Oncogenomics, Revvity, CareDx, Natera, BillionToOne, Inc., Yourgene Health, ARUP Laboratories and Roche, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global cfDNA Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of cfDNA Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents cfDNA Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global cfDNA Testing market.

cfDNA Testing Segment by Company

Illumina

Oncogenomics

Revvity

CareDx

Natera

BillionToOne, Inc.

Yourgene Health

ARUP Laboratories

Roche

cfDNA Testing Segment by Type

Targeted Sequencing

Whole Genome Sequencing

cfDNA Testing Segment by Application

Prenatal Testing

Oncology

Organ Transplant Monitoring

Others

cfDNA Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global cfDNA Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the cfDNA Testing key companies, revenue, market share, and recent developments.

3. To split the cfDNA Testing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions cfDNA Testing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify cfDNA Testing significant trends, drivers, influence factors in global and regions.

6. To analyze cfDNA Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global cfDNA Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of cfDNA Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of cfDNA Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global cfDNA Testing industry.

Chapter 3: Detailed analysis of cfDNA Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of cfDNA Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of cfDNA Testing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. cfDNA Testing Industry Trends Table 2. cfDNA Testing Industry Drivers Table 3. cfDNA Testing Industry Opportunities and Challenges Table 4. cfDNA Testing Industry Restraints Table 5. Global cfDNA Testing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global cfDNA Testing Revenue Share by Company (2021-2026) Table 7. Global cfDNA Testing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global cfDNA Testing Key Company Manufacturing Base & Headquarters Table 9. Global cfDNA Testing Company, Product Type & Application Table 10. Global cfDNA Testing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global cfDNA Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Targeted Sequencing Table 15. Significant Companies of Whole Genome Sequencing Table 16. Global cfDNA Testing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global cfDNA Testing Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global cfDNA Testing Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global cfDNA Testing Sales Value Share by Type (2021-2026) Table 20. Global cfDNA Testing Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Prenatal Testing Table 22. Significant Companies of Oncology Table 23. Significant Companies of Organ Transplant Monitoring Table 24. Significant Companies of Others Table 25. Global cfDNA Testing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global cfDNA Testing Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global cfDNA Testing Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global cfDNA Testing Sales Value Share by Application (2021-2026) Table 29. Global cfDNA Testing Sales Value Share by Application (2027-2032) Table 30. Global cfDNA Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global cfDNA Testing Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global cfDNA Testing Sales Value Share by Region (2021-2026) Table 33. Global cfDNA Testing Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global cfDNA Testing Sales Value Share by Region (2027-2032) Table 35. Global cfDNA Testing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global cfDNA Testing Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global cfDNA Testing Sales Value Market Share by Country (2021-2026) Table 38. Global cfDNA Testing Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global cfDNA Testing Sales Value Market Share by Country (2027-2032) Table 40. Illumina Company Information Table 41. Illumina Business Overview Table 42. Illumina cfDNA Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Illumina cfDNA Testing Product Portfolio Table 44. Illumina Recent Development Table 45. Oncogenomics Company Information Table 46. Oncogenomics Business Overview Table 47. Oncogenomics cfDNA Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Oncogenomics cfDNA Testing Product Portfolio Table 49. Oncogenomics Recent Development Table 50. Revvity Company Information Table 51. Revvity Business Overview Table 52. Revvity cfDNA Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Revvity cfDNA Testing Product Portfolio Table 54. Revvity Recent Development Table 55. CareDx Company Information Table 56. CareDx Business Overview Table 57. CareDx cfDNA Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. CareDx cfDNA Testing Product Portfolio Table 59. CareDx Recent Development Table 60. Natera Company Information Table 61. Natera Business Overview Table 62. Natera cfDNA Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Natera cfDNA Testing Product Portfolio Table 64. Natera Recent Development Table 65. BillionToOne, Inc. Company Information Table 66. BillionToOne, Inc. Business Overview Table 67. BillionToOne, Inc. cfDNA Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. BillionToOne, Inc. cfDNA Testing Product Portfolio Table 69. BillionToOne, Inc. Recent Development Table 70. Yourgene Health Company Information Table 71. Yourgene Health Business Overview Table 72. Yourgene Health cfDNA Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Yourgene Health cfDNA Testing Product Portfolio Table 74. Yourgene Health Recent Development Table 75. ARUP Laboratories Company Information Table 76. ARUP Laboratories Business Overview Table 77. ARUP Laboratories cfDNA Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. ARUP Laboratories cfDNA Testing Product Portfolio Table 79. ARUP Laboratories Recent Development Table 80. Roche Company Information Table 81. Roche Business Overview Table 82. Roche cfDNA Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Roche cfDNA Testing Product Portfolio Table 84. Roche Recent Development Table 85. Research Programs/Design for This Report Table 86. Authors List of This Report Table 87. Secondary Sources Table 88. Primary Sources List of Figures Figure 1. cfDNA Testing Product Image Figure 2. Global cfDNA Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global cfDNA Testing Market Size (2021-2032) & (US$ Million) Figure 4. Global cfDNA Testing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Targeted Sequencing Image Figure 8. Whole Genome Sequencing Image Figure 9. Global cfDNA Testing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global cfDNA Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global cfDNA Testing Sales Value Share by Type (2021-2032) Figure 12. Prenatal Testing Image Figure 13. Oncology Image Figure 14. Organ Transplant Monitoring Image Figure 15. Others Image Figure 16. Global cfDNA Testing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global cfDNA Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global cfDNA Testing Sales Value Share by Application (2021-2032) Figure 19. Global cfDNA Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global cfDNA Testing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America cfDNA Testing Sales Value (2021-2032) & (US$ Million) Figure 22. North America cfDNA Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe cfDNA Testing Sales Value (2021-2032) & (US$ Million) Figure 24. Europe cfDNA Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific cfDNA Testing Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific cfDNA Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America cfDNA Testing Sales Value (2021-2032) & (US$ Million) Figure 28. South America cfDNA Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa cfDNA Testing Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa cfDNA Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA cfDNA Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA cfDNA Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA cfDNA Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada cfDNA Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada cfDNA Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada cfDNA Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico cfDNA Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico cfDNA Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico cfDNA Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany cfDNA Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany cfDNA Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany cfDNA Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France cfDNA Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France cfDNA Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France cfDNA Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. cfDNA Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. cfDNA Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. cfDNA Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy cfDNA Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy cfDNA Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy cfDNA Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain cfDNA Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain cfDNA Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain cfDNA Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia cfDNA Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia cfDNA Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia cfDNA Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands cfDNA Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands cfDNA Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands cfDNA Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries cfDNA Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries cfDNA Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries cfDNA Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China cfDNA Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China cfDNA Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China cfDNA Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan cfDNA Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan cfDNA Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan cfDNA Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea cfDNA Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea cfDNA Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea cfDNA Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India cfDNA Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India cfDNA Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India cfDNA Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia cfDNA Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia cfDNA Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia cfDNA Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia cfDNA Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia cfDNA Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia cfDNA Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil cfDNA Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil cfDNA Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil cfDNA Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina cfDNA Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina cfDNA Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina cfDNA Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile cfDNA Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile cfDNA Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile cfDNA Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia cfDNA Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia cfDNA Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia cfDNA Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru cfDNA Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru cfDNA Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru cfDNA Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia cfDNA Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia cfDNA Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia cfDNA Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel cfDNA Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel cfDNA Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel cfDNA Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE cfDNA Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE cfDNA Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE cfDNA Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey cfDNA Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey cfDNA Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey cfDNA Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran cfDNA Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran cfDNA Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran cfDNA Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt cfDNA Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt cfDNA Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt cfDNA Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Targeted Sequencing
  • Whole Genome Sequencing
Applications
  • Prenatal Testing
  • Oncology
  • Organ Transplant Monitoring
  • Others
Companies covered
  • Illumina
  • Oncogenomics
  • Revvity
  • CareDx
  • Natera
  • BillionToOne, Inc.
  • Yourgene Health
  • ARUP Laboratories
  • Roche

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global cfDNA Testing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global cfDNA Testing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 cfDNA Testing Market Dynamics
  1. 2.1 cfDNA Testing Industry Trends
  2. 2.2 cfDNA Testing Industry Drivers
  3. 2.3 cfDNA Testing Industry Opportunities and Challenges
  4. 2.4 cfDNA Testing Industry Restraints
3 cfDNA Testing Market by Company
  1. 3.1 Global cfDNA Testing Company Revenue Ranking in 2025
  2. 3.2 Global cfDNA Testing Revenue by Company (2021-2026)
  3. 3.3 Global cfDNA Testing Company Ranking (2024-2026)
  4. 3.4 Global cfDNA Testing Company Manufacturing Base and Headquarters
  5. 3.5 Global cfDNA Testing Company Product Type and Application
  6. 3.6 Global cfDNA Testing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global cfDNA Testing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 cfDNA Testing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 cfDNA Testing Market by Type
  1. 4.1 cfDNA Testing Type Introduction
  2. 4.1.1 Targeted Sequencing
  3. 4.1.2 Whole Genome Sequencing
  4. 4.2 Global cfDNA Testing Sales Value by Type
  5. 4.2.1 Global cfDNA Testing Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global cfDNA Testing Sales Value by Type (2021-2032)
  7. 4.2.3 Global cfDNA Testing Sales Value Share by Type (2021-2032)
5 cfDNA Testing Market by Application
  1. 5.1 cfDNA Testing Application Introduction
  2. 5.1.1 Prenatal Testing
  3. 5.1.2 Oncology
  4. 5.1.3 Organ Transplant Monitoring
  5. 5.1.4 Others
  6. 5.2 Global cfDNA Testing Sales Value by Application
  7. 5.2.1 Global cfDNA Testing Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global cfDNA Testing Sales Value by Application (2021-2032)
  9. 5.2.3 Global cfDNA Testing Sales Value Share by Application (2021-2032)
6 cfDNA Testing Regional Value Analysis
  1. 6.1 Global cfDNA Testing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global cfDNA Testing Sales Value by Region (2021-2032)
  3. 6.2.1 Global cfDNA Testing Sales Value by Region: 2021-2026
  4. 6.2.2 Global cfDNA Testing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America cfDNA Testing Sales Value (2021-2032)
  7. 6.3.2 North America cfDNA Testing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe cfDNA Testing Sales Value (2021-2032)
  10. 6.4.2 Europe cfDNA Testing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific cfDNA Testing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific cfDNA Testing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America cfDNA Testing Sales Value (2021-2032)
  16. 6.6.2 South America cfDNA Testing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa cfDNA Testing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa cfDNA Testing Sales Value Share by Country, 2025 VS 2032
7 cfDNA Testing Country-level Value Analysis
  1. 7.1 Global cfDNA Testing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global cfDNA Testing Sales Value by Country (2021-2032)
  3. 7.2.1 Global cfDNA Testing Sales Value by Country (2021-2026)
  4. 7.2.2 Global cfDNA Testing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA cfDNA Testing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA cfDNA Testing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA cfDNA Testing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada cfDNA Testing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada cfDNA Testing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada cfDNA Testing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico cfDNA Testing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico cfDNA Testing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico cfDNA Testing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany cfDNA Testing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany cfDNA Testing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany cfDNA Testing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France cfDNA Testing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France cfDNA Testing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France cfDNA Testing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. cfDNA Testing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. cfDNA Testing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. cfDNA Testing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy cfDNA Testing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy cfDNA Testing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy cfDNA Testing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain cfDNA Testing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain cfDNA Testing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain cfDNA Testing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia cfDNA Testing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia cfDNA Testing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia cfDNA Testing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands cfDNA Testing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands cfDNA Testing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands cfDNA Testing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries cfDNA Testing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries cfDNA Testing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries cfDNA Testing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China cfDNA Testing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China cfDNA Testing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China cfDNA Testing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan cfDNA Testing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan cfDNA Testing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan cfDNA Testing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea cfDNA Testing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea cfDNA Testing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea cfDNA Testing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India cfDNA Testing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India cfDNA Testing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India cfDNA Testing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia cfDNA Testing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia cfDNA Testing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia cfDNA Testing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia cfDNA Testing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia cfDNA Testing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia cfDNA Testing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil cfDNA Testing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil cfDNA Testing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil cfDNA Testing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina cfDNA Testing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina cfDNA Testing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina cfDNA Testing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile cfDNA Testing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile cfDNA Testing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile cfDNA Testing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia cfDNA Testing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia cfDNA Testing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia cfDNA Testing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru cfDNA Testing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru cfDNA Testing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru cfDNA Testing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia cfDNA Testing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia cfDNA Testing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia cfDNA Testing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel cfDNA Testing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel cfDNA Testing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel cfDNA Testing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE cfDNA Testing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE cfDNA Testing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE cfDNA Testing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey cfDNA Testing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey cfDNA Testing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey cfDNA Testing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran cfDNA Testing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran cfDNA Testing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran cfDNA Testing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt cfDNA Testing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt cfDNA Testing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt cfDNA Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Illumina
  2. 8.1.1 Illumina Company Information
  3. 8.1.2 Illumina Business Overview
  4. 8.1.3 Illumina cfDNA Testing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Illumina cfDNA Testing Product Portfolio
  6. 8.1.5 Illumina Recent Developments
  7. 8.2 Oncogenomics
  8. 8.2.1 Oncogenomics Company Information
  9. 8.2.2 Oncogenomics Business Overview
  10. 8.2.3 Oncogenomics cfDNA Testing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Oncogenomics cfDNA Testing Product Portfolio
  12. 8.2.5 Oncogenomics Recent Developments
  13. 8.3 Revvity
  14. 8.3.1 Revvity Company Information
  15. 8.3.2 Revvity Business Overview
  16. 8.3.3 Revvity cfDNA Testing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Revvity cfDNA Testing Product Portfolio
  18. 8.3.5 Revvity Recent Developments
  19. 8.4 CareDx
  20. 8.4.1 CareDx Company Information
  21. 8.4.2 CareDx Business Overview
  22. 8.4.3 CareDx cfDNA Testing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 CareDx cfDNA Testing Product Portfolio
  24. 8.4.5 CareDx Recent Developments
  25. 8.5 Natera
  26. 8.5.1 Natera Company Information
  27. 8.5.2 Natera Business Overview
  28. 8.5.3 Natera cfDNA Testing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Natera cfDNA Testing Product Portfolio
  30. 8.5.5 Natera Recent Developments
  31. 8.6 BillionToOne, Inc.
  32. 8.6.1 BillionToOne, Inc. Company Information
  33. 8.6.2 BillionToOne, Inc. Business Overview
  34. 8.6.3 BillionToOne, Inc. cfDNA Testing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 BillionToOne, Inc. cfDNA Testing Product Portfolio
  36. 8.6.5 BillionToOne, Inc. Recent Developments
  37. 8.7 Yourgene Health
  38. 8.7.1 Yourgene Health Company Information
  39. 8.7.2 Yourgene Health Business Overview
  40. 8.7.3 Yourgene Health cfDNA Testing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Yourgene Health cfDNA Testing Product Portfolio
  42. 8.7.5 Yourgene Health Recent Developments
  43. 8.8 ARUP Laboratories
  44. 8.8.1 ARUP Laboratories Company Information
  45. 8.8.2 ARUP Laboratories Business Overview
  46. 8.8.3 ARUP Laboratories cfDNA Testing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 ARUP Laboratories cfDNA Testing Product Portfolio
  48. 8.8.5 ARUP Laboratories Recent Developments
  49. 8.9 Roche
  50. 8.9.1 Roche Company Information
  51. 8.9.2 Roche Business Overview
  52. 8.9.3 Roche cfDNA Testing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Roche cfDNA Testing Product Portfolio
  54. 8.9.5 Roche Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst